Introduction To what degree population-level antibiotic use contributes to Neisseria gonorrhoeae (NG) resistance in the US is unclear. We investigated whether outpatient prescribing is associated with NG antibiotic susceptibility. Methods Using data from the Gonococcal Isolate Surveillance Project (GISP; a US surveillance system that samples male urethral isolates) during 2005-2013, we calculated annual geometric mean minimum inhibitory concentrations (MICs) of azithromycin, cefixime, and ceftriaxone by site. We used QuintilesIMS data (captures>70% of US outpatient prescriptions and projects to 100% coverage) to calculate annual cephalosporin and macrolide rates prescribing per 1000 men by each county corresponding to a GISP site. For descriptive analyses, we calculated site-specific medians of these measures. We constructed multivariable linear mixed models for each agent with annual prescribing rates as the exposure and one-year lagged geometric mean MIC as the outcome. (66%) is under 50 years old and a considerable number (32%) of individuals survived until two years after the diagnosis. Late-diagnosis, late implementation of TARV and poor adhesion are notable among the deaths, as well as a significant ratio (29%) of substance-abusing individuals. AIDS-defining illnesses (particularly tuberculosis) rank as the highest causes of death (55%) followed by non-AIDSdefining bacterial infections (18%), which are both predominant among the deaths of those patients with therapeutic disruption and/or advanced HIV infection. Causes unrelated to HIV and bacterial infections are predominant among patients with suppression of HIV-replication and recent CD4 count above 500 cells/mm 3 . Conclusion Even in light of a positive context due to the decrease of MR, the oversight of deaths of HIV-infected individuals remains a fundamental practice for identifying vulnerabilities and works as a guiding principle for interventions that may contribute to a decrease in the number of avoidabledeaths. The results indicate the relevance of actions towards early-diagnosing, monitoring of patient-enrollment and adhesion to services, timely start of antiretroviral therapy, continued oversight of patient-adhesion to medications and diagnosis as well as towards the treatment of potentially-avoidable conditions such as latent infection of tuberculosis and vaccination for pneumococo. Some groups -such as drug and alcoholabusing individuals -require a case-by-case approach. 
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